Latest news

On 11 March 2022, Nanologica AB (publ) announced that Nasdaq Stockholm’s Listing Committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market, conditioned upon customary conditions being fulfilled. The prospectus prepared in connection with the listing has today been approved and registered by the Swedish Financial Supervisory Authority and is now available on Nanologica’s website www.nanologica.com and will be made available on the Swedish Financial Supervisory Authority’s website www.fi.se.

Nanologica AB (publ) announces that Nasdaq Stockholm’s Listing Committee has approved the company’s application for admission to trading of the company’s shares on Nasdaq Stockholm’s main market. The approval is conditioned upon customary conditions being fulfilled, including the approval and registration of a prospectus by the Swedish Financial Supervisory Authority. The first day of trading on Nasdaq Stockholm’s main market is scheduled for Tuesday 29 March 2022 and the last day of trading on Spotlight

Nanologica’s annual report for the financial year 2021 has been published and is now available on the company’s website. The annual report can be downloaded from the company’s website www.nanologica.com (Investor Relations/Finansiella rapporter) and is also attached to the press release. An English translation of the annual report is expected to be available on the company’s website in mid-March.     For further information, please contact: Johanna Johansson, Director IR, Communications and Marketing Ph: +46